David Shaw’s Estrella Immunopharma Warrant ESLAW Stock Holding History

David Shaw’s Portfolio ESLAW Stock Details ESLAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.5K	Hold	87,500	–	–	﹤0.01%	4774
2026 Q1	$6.13K	Hold	87,500	–	–	﹤0.01%	4432
2025 Q4	$4.38K	Hold	87,500	–	–	﹤0.01%	4531
2025 Q3	$4.55K	Hold	87,500	–	–	﹤0.01%	4485
2025 Q2	$3.81K	Hold	87,500	–	–	﹤0.01%	4284
2025 Q1	$6.74K	Hold	87,500	–	–	﹤0.01%	4150
2024 Q4	$7.69K	Hold	87,500	–	–	﹤0.01%	4290
2024 Q3	$6.13K	Hold	87,500	–	–	﹤0.01%	4410
2024 Q2	$6.93K	Hold	87,500	–	–	﹤0.01%	4343
2024 Q1	$6.05K	Hold	87,500	–	–	﹤0.01%	4205
2023 Q4	$4.26K	Hold	87,500	–	–	﹤0.01%	4188
2023 Q3	$21K	Hold	87,500	–	–	﹤0.01%	3981
2023 Q2	$3.45K	Hold	87,500	–	–	﹤0.01%	4133
2023 Q1	$12.1K	Hold	87,500	–	–	﹤0.01%	4208
2022 Q4	$4.55K	Hold	87,500	–	–	﹤0.01%	4692
2022 Q3	$6K	Hold	87,500	–	–	﹤0.01%	4995
2022 Q2	$27K	Hold	87,500	–	–	﹤0.01%	4953
2022 Q1	$20K	Hold	87,500	–	–	﹤0.01%	5333
2021 Q4	$44K	Hold	87,500	–	–	﹤0.01%	5219
2021 Q3	$36K	Buy	+87,500	New	+$35.9K	﹤0.01%	4857

Other funds holding ESLAW

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return

Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 14.02% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

David Shaw's ESLAW Position: Q2 2026 in Review

David Shaw held its Estrella Immunopharma Warrant (ESLAW) position steady in Q2 2026 at 87,500 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4774.

David Shaw first reported a position in ESLAW in Q3 2021 and has held it in 20 quarters since. The position peaked at $44K in Q4 2021. 7 funds tracked by Wall St. Rank hold ESLAW as of Q2 2026.

David Shaw held 87,500 shares of Estrella Immunopharma Warrant worth $12.5K as of Q2 2026.
David Shaw left its Estrella Immunopharma Warrant share count unchanged in Q2 2026.
Estrella Immunopharma Warrant made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4774 holding.
David Shaw first reported a position in Estrella Immunopharma Warrant in Q3 2021 and has held it in 20 quarters since.
David Shaw's Estrella Immunopharma Warrant position peaked at $44K in Q4 2021.
7 funds tracked by Wall St. Rank held Estrella Immunopharma Warrant as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.